Moreover, this research showed elevated CSF NSE levels in ALS via the subgroup analyses of male and female patients and those aged < 70 and ≥ 70 years, which were performed to control the confounding effects of age and sex. The gene discussed is ENO2; the disease is amyotrophic lateral sclerosis.